Bio-Rad Laboratories anti-ipilimumab antibodies

Wednesday, 22 April, 2020 | Supplied by: Bio-Rad Laboratories Pty Ltd


Bio-Rad Laboratories offers a portfolio of recombinant, monoclonal anti-idiotypic antibodies and drug-target complex binders for the development of highly selective and sensitive assays to support researchers in developing robust methods in a short timescale and generating translatable and defensible results. Now, the company has extended its range with the introduction of antibodies that are specific for ipilimumab (Yervoy) and the ipilimumab/CTLA-4 drug-target complex. These highly specific and high-affinity antibodies are suitable for bioanalytical and patient drug level monitoring assays for the immune checkpoint inhibitor: ipilimumab.

Ipilimumab activates the immune system by inhibiting cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a protein receptor that hinders the destruction of cancerous cells, to treat cancers such as melanoma. The four anti-ipilimumab antibodies inhibit the binding of the drug to its target, CTLA-4, and therefore detect free drug. These antibodies are suitable for developing pharmacokinetic (PK) bridging ELISAs and being used as a surrogate positive control (or reference standard) for anti-drug antibody assays. The drug-target complex binder specifically recognises the ipilimumab/CTLA-4 complex and can be used as the detection antibody in a PK antigen capture assay as an alternative format to the bridging ELISA.

The recombinant monoclonal anti-idiotypic antibodies are generated using the Human Combinatorial Antibody Library (HuCAL) and CysDisplay, a proprietary method of phage display with guided selection methods to obtain highly targeted reagents. The recombinant production method also ensures a consistent and secure supply.

The anti-ipilimumab antibodies are approved for in vitro research and for commercial applications of in vitro testing services that support preclinical and clinical drug and biosimilar development and patient monitoring. In vitro production means the antibodies will deliver consistent results across PK assays.

Online: www.bio-rad.com
Phone: 02 9914 2800
Related Products

HAWK Biosystems Quantifying Functions in Proteins (QF-Pro) reagent kits

HAWK Biosystems' Quantifying Functions in Proteins (QF-Pro) reagent kits contain the tailored...

Amsbio validated cytokines for organoid culture

Amsbio has launched over a range of over 30 independently developed and manufactured organoid...

Dendritics monoclonal antibodies for dendritic cell research

Dendritics' mouse and rat antibodies are logically grouped into several product families: DC...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd